IT1224886B - Monoesteri idrosolubili impiegabili come solubilizzanti per sostanze farmacologicamente attive - Google Patents

Monoesteri idrosolubili impiegabili come solubilizzanti per sostanze farmacologicamente attive

Info

Publication number
IT1224886B
IT1224886B IT8848349A IT4834988A IT1224886B IT 1224886 B IT1224886 B IT 1224886B IT 8848349 A IT8848349 A IT 8848349A IT 4834988 A IT4834988 A IT 4834988A IT 1224886 B IT1224886 B IT 1224886B
Authority
IT
Italy
Prior art keywords
solubilizers
water soluble
active substances
pharmacologically active
soluble monoesters
Prior art date
Application number
IT8848349A
Other languages
English (en)
Italian (it)
Other versions
IT8848349A0 (it
Inventor
Hahn Lorenz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8848349A0 publication Critical patent/IT8848349A0/it
Application granted granted Critical
Publication of IT1224886B publication Critical patent/IT1224886B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8848349A 1987-09-15 1988-09-14 Monoesteri idrosolubili impiegabili come solubilizzanti per sostanze farmacologicamente attive IT1224886B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (2)

Publication Number Publication Date
IT8848349A0 IT8848349A0 (it) 1988-09-14
IT1224886B true IT1224886B (it) 1990-10-24

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848349A IT1224886B (it) 1987-09-15 1988-09-14 Monoesteri idrosolubili impiegabili come solubilizzanti per sostanze farmacologicamente attive

Country Status (24)

Country Link
JP (1) JP3090666B2 (da)
KR (1) KR0131084B1 (da)
AT (1) AT395819B (da)
AU (1) AU628787B2 (da)
BE (1) BE1001204A5 (da)
CA (1) CA1338775C (da)
CH (1) CH683672A5 (da)
DK (1) DK175132B1 (da)
ES (1) ES2012118A6 (da)
FI (1) FI94837C (da)
FR (1) FR2620336B1 (da)
GB (1) GB2209671B (da)
GR (1) GR1002243B (da)
HU (1) HU205010B (da)
IE (1) IE61195B1 (da)
IL (1) IL87746A (da)
IT (1) IT1224886B (da)
LU (1) LU87335A1 (da)
MY (1) MY103769A (da)
NL (1) NL195094C (da)
NO (1) NO179434C (da)
NZ (1) NZ226163A (da)
PT (1) PT88492B (da)
SE (1) SE503279C2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GR1000466B (el) * 1989-01-28 1992-07-30 Sandoz Ag Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
DK1033128T4 (da) 1993-09-28 2012-03-19 Scherer Gmbh R P Blød gelatinekapselfremstilling
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
PT988046E (pt) 1997-01-30 2004-12-31 Novartis Ag Composicoes farmaceuticas sem oleo contendo ciclosporina a
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AU2003267747A1 (en) * 2003-10-14 2005-05-05 Ramesh Varada Bapat Sterile gelling agents
JP5422871B2 (ja) * 2006-10-24 2014-02-19 不二製油株式会社 イソフラボン類組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284933A (da) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (da) * 1966-11-22 1968-06-21
BE787842A (fr) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd Procede de preparation d'une suspension aqueuse de cristaux stables du type non beta d'esters d'acides gras superieurs du chloramphenicol
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤

Also Published As

Publication number Publication date
JP3090666B2 (ja) 2000-09-25
PT88492A (pt) 1988-10-01
LU87335A1 (fr) 1989-04-06
FR2620336A1 (fr) 1989-03-17
SE8803221L (sv) 1989-03-16
NL195094C (nl) 2003-12-17
SE8803221D0 (sv) 1988-09-13
NO179434B (no) 1996-07-01
DK175132B1 (da) 2004-06-14
NO884052L (no) 1989-03-16
HUT49494A (en) 1989-10-30
ES2012118A6 (es) 1990-03-01
SE503279C2 (sv) 1996-05-13
FR2620336B1 (fr) 1991-10-25
FI94837B (fi) 1995-07-31
FI884192A0 (fi) 1988-09-13
FI884192L (fi) 1989-03-16
IT8848349A0 (it) 1988-09-14
KR0131084B1 (ko) 1998-04-17
HU205010B (en) 1992-03-30
FI94837C (fi) 1995-11-10
AT395819B (de) 1993-03-25
GB8821443D0 (en) 1988-10-12
NO884052D0 (no) 1988-09-13
CA1338775C (en) 1996-12-10
GB2209671B (en) 1991-11-13
IE882772L (en) 1989-03-15
BE1001204A5 (fr) 1989-08-16
GR880100602A (el) 1989-06-22
KR890004694A (ko) 1989-05-09
PT88492B (pt) 1993-03-31
NO179434C (no) 1996-10-09
MY103769A (en) 1993-09-30
GB2209671A (en) 1989-05-24
GR1002243B (en) 1996-04-22
AU2217288A (en) 1989-04-27
IL87746A (en) 1992-07-15
IL87746A0 (en) 1989-02-28
NL8802275A (nl) 1989-04-03
IE61195B1 (en) 1994-10-19
DK511188A (da) 1989-03-16
CH683672A5 (de) 1994-04-29
ATA224988A (de) 1992-08-15
JPH01151526A (ja) 1989-06-14
AU628787B2 (en) 1992-09-24
DK511188D0 (da) 1988-09-14
NZ226163A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
IT8848349A0 (it) Monoesteri idrosolubili impiegabili come solubilizzanti per sostanze farmacologicamente attive
KR890701031A (ko) 수용성 충전제(Water soluble bulking agents)
KR880005932A (ko) 신경중독손상을 감소시키기 위한 약제 조성물
ATA246487A (de) Spundfass
IT1222104B (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina
DK686487D0 (da) 1h-imidazol-5-carboxylsyrederivater
IT1222103B (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina
IT1221276B (it) Dispositivo per il trasporto di elementi in lavorazione
TR22963A (tr) Boyut itibariyle eski haline geri doenebilen mansonlara mahsus goesterge
DK445188D0 (da) Vandoploeseligt antibiotisk praeparat
IT8767234A0 (it) Dispositivo atto ad evitare il ribaltamento di catamarani
DK405988D0 (da) Benzimidazolderivater
ES2014335B3 (es) Jigger
FR2624353B1 (fr) Couche-culotte
FR2610498B1 (fr) Treteau
NO172223C (no) Dekk for tankfartoey
FI892635A7 (fi) Vetoankkuri
DK46288A (da) Pilocarpinderivater
ATA87988A (de) Pflugnachlaeufer
FI875379L (fi) Koostumuksia käytettäviksi tomodensitometriassa
KR890002794U (ko) 탈수통 착탈구조
ATA78088A (de) Pflugnachlaeufer
KR890008945U (ko) 건축용 보울트레스(bolt less)판재
ES1004104Y (es) Tarima desmontable
AT386814B (de) Sattelzug

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970714